Evercore ISI analyst Umer Raffat maintained a Hold rating on Eli Lilly & Co (LLY – Research Report) yesterday. The company’s shares closed ...

Novo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.

Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

Editor's note: This article was updated at 145p ET with comment from Evercore ISI analyst Umer Raffat. The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new ...

IHC’s Justice Saman Raffat Imtiaz heard and disposed of the petition filed by PTI leader seeking cases details against her. During the course of proceeding, DSP Legal Islamabad Police Sajid ...